COMMUNIQUÉS West-GlobeNewswire

Nurix Therapeutics Announces Multiple Presentations Showcasing Depth of Research Pipeline and Scientific Leadership at the American Association for Cancer Research (AACR) 2026 Annual Meeting
23/03/2026
BRISBANE, Calif., March 23, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein [...]
Aardvark Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
23/03/2026
Voluntary pause of the Phase 3 HERO and OLE trials evaluating ARD-101 for the treatment of hyperphagia in individuals with Prader-Willi Syndrome, further guidance on the program expected in Q2 2026 ARD-201 obesity [...]
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates
23/03/2026
Abivax Announces Full Year 2025 Financial Results and Provides Business Updates ABTECT Phase 3 Data Safety Monitoring Board (DSMB) meeting on March 18, 2026 found no new safety signals; the analysis included 100% of [...]
Avalyn Announces First Patient Dosed in AURA Phase 2 Clinical Trial Evaluating AP02, Inhaled Nintedanib, for the Treatment of Idiopathic Pulmonary Fibrosis
23/03/2026
AURA Phase 2 clinical trial designed to evaluate the safety and efficacy of AP02 compared to placebo in patients with idiopathic pulmonary fibrosis (IPF) BOSTON, March 23, 2026 (GLOBE NEWSWIRE) -- Avalyn, a clinical- [...]
Apogee Therapeutics, Inc. Announces Proposed $300 Million Underwritten Public Offering
23/03/2026
SAN FRANCISCO and BOSTON, March 23, 2026 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing optimized, novel biologics with the potential for best-in-class [...]
Stryker announces Annual Meeting of Shareholders
23/03/2026
Portage, Michigan, March 23, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced its 2026 Annual Meeting of Shareholders is scheduled as follows: Wednesday, May 6, 2026 – 12:00 p.m. Eastern Time The Meeting will be [...]
MEDVi Quad Prescription Access Updated as Telehealth ED Treatment Demand Rises in 2026
23/03/2026
Los Angeles, March 23, 2026 (GLOBE NEWSWIRE) -- As demand for telehealth erectile dysfunction treatment access continues to grow in 2026, updated disclosures for MEDVi Quad , a prescription-only ED treatment, have been [...]
NMDP(SM) Advances Cell Therapy Research in Clinical Practice and Patient Outcomes at EBMT 2026
23/03/2026
Real-world data advances new insights into donor selection, benchmarks for patient infection prevention and comparative outcomes in a modern post-transplant cyclophosphamide (PTCy) era MINNEAPOLIS, March 23, 2026 (GLOBE [...]
OSE Immunotherapeutics to Present at Upcoming Investor Conferences
23/03/2026
Nantes, France, March 23, 2026 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) , a clinical-stage biotech company dedicated to developing first-in-class therapies in immuno-oncology and immuno- [...]
OSE Immunotherapeutics invitée à présenter lors des prochaines conférences investisseurs
23/03/2026
Nantes, France, 23 mars 2026 – 18h00 CET – OSE Immunotherapeutics SA (ISIN : FR0012127173 ; Mnemo : OSE) , une société de biotechnologie au stade clinique développant des thérapies first-in-class en immuno-oncologie et [...]
Resolutions from the Annual General Meeting 2026
23/03/2026
Today, the Annual General Meeting of Novonesis (Novozymes A/S) was conducted. The following resolutions were made: Approval of the audited Annual Report for 2025 Approval of distribution of profit with payment of an [...]
BioStem Appoints Jodi Ungrodt to Board of Directors as Audit Committee Chair
23/03/2026
SEC-Qualified Financial Expert and Life Sciences Veteran Brings 29 Years of Accounting Leadership to the Board Pompano Beach, FL, March 23, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies, a leading MedTech company [...]
Standard Dental Labs Inc. Engages Strategic Advisor to Support Lab Acquisition Strategy
23/03/2026
ORLANDO, Fla., March 23, 2026 (GLOBE NEWSWIRE) -- Standard Dental Labs Inc. (“SDL” or the “Company”) today announced it has entered into an agreement with EMAC Capital LLC (“EMAC”) to provide strategic advisory services [...]
Siren Biotechnology Announces FDA Clearance of Investigator-Initiated IND to Advance Phase 1 Study in Recurrent High-Grade Glioma
23/03/2026
SAN FRANCISCO, March 23, 2026 (GLOBE NEWSWIRE) -- Siren Biotechnology today announced that the U.S. Food and Drug Administration (FDA) has cleared an Investigational New Drug (IND) application submitted by the [...]
Checkerspot Announces Breakthrough, using Microalgae to Produce Palmitoleic Acid Oil at Scale, Opening a New Pathway to Omega-7s
23/03/2026
Peer-reviewed study in the Journal Fermentation details Checkerspot achieving up to 58% palmitoleic acid content, establishing a scalable, sustainable Omega-7 alternative to macadamia nuts, sea buckthorn, and fish- [...]
Roche inaugurates new research home for the Institute of Human Biology, pioneering human model systems to accelerate drug discovery and development
23/03/2026
The new building is part of a CHF 1.4 billion site investment, reinforcing Roche’s commitment to Switzerland and the Basel life sciences cluster The Institute of Human Biology (IHB) enables scientists to pioneer human [...]
AdipoPharma Enters Clinic with First-in-Class Therapy Targeting Type 2 diabetes with the potential to maintain muscle mass
23/03/2026
This novel whole-body insulin-sensitizing approach is designed to address insulin resistance independent of weight loss PITTSBURGH, March 23, 2026 (GLOBE NEWSWIRE) -- As GLP-1 therapies reshape obesity care, one biotech [...]
Children’s National launches Division of AI Research to lead the future of artificial intelligence in pediatric medicine
23/03/2026
New division will build infrastructure to bring trustworthy, clinically grounded AI to help care for kids Washington, DC, March 23, 2026 (GLOBE NEWSWIRE) -- Children’s National Hospital has launched the Division of AI [...]
Umoja Biopharma Appoints Dr. Marcela Maus and Dr. Athena Countouriotis to Board of Directors
23/03/2026
SEATTLE, March 23, 2026 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), a clinical-stage biotechnology company committed to delivering innovative and potentially curative immunotherapies for patients with cancer and [...]

Pages